Selective Deuteration and Tritiation of Pharmaceutically Relevant Sulfoximines
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202417179 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Blair I P Smith und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow, Scotland, G1 1XL, UK. Hauptthemen laut MEDLINE: Deuterium, Tritium, Imines. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Engineering and Physical Sciences Research Council, University of Strathclyde.
Abstract (Originalsprache)
Pharmaceutical‐aligned research endeavors continue to diversify, including via the installation of new chemical functionality and non‐classical bioisosteres within drug design. With this, an equally high demand emerges for the direct installation of isotopic substituents into these scaffolds within drug discovery programmes, as isotopologues are essential for the elucidation of the biological efficacy and metabolic fate of the active pharmaceutical ingredient (API). The sulfoximine functional group has recently become established as a high‐value unit in this context; however, general and effective methods for the synthesis of deuterium ( 2 H, D) and tritium ( 3 H, T) labelled analogues have remained elusive. Herein, we disclose the design and development of the first iridium‐catalyzed sulfoximine‐directed hydrogen isotope exchange (HIE) systems that permit the site‐selective integration of a distinguishing atomic label at aromatic C( sp 2 )−H and more challenging C( sp 3 )−H moieties. Moreover, we exemplify the broad applicability of these methods within a spectrum of molecular settings, as well as in the late‐stage generation of isotopically‐enriched complex bioactive architectures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, Glasgow, Scotland, G1 1XL, UK.
- Early Chemical Development Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, SE-43183, Sweden.
- Early Chemical Development Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, England, CB2 0AA, UK.
ORCID-Profile: Blair I P Smith, Nathan M L Knight, Gary J Knox, David M Lindsay, Laura C Paterson, Charles S Elmore, Ryan A Bragg, William J Kerr
Förderung
- Engineering and Physical Sciences Research Council
- University of Strathclyde
Zitieren
APA
Smith, B. I. P., Knight, N. M. L., Knox, G. J., Lindsay, D. M., Paterson, L. C., Bergare, J., Elmore, C. S., Bragg, R. A., & Kerr, W. J. (2025). Selective Deuteration and Tritiation of Pharmaceutically Relevant Sulfoximines. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202417179
Vancouver
Smith BIP, Knight NML, Knox GJ, Lindsay DM, Paterson LC, Bergare J, et al. Selective Deuteration and Tritiation of Pharmaceutically Relevant Sulfoximines. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202417179
BibTeX
@article{Smith2025,
author = {Smith, Blair I P and Knight, Nathan M L and Knox, Gary J and Lindsay, David M and Paterson, Laura C and Bergare, Jonas and Elmore, Charles S and Bragg, Ryan A and Kerr, William J},
title = {Selective Deuteration and Tritiation of Pharmaceutically Relevant Sulfoximines},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202417179}
}
EUVIMED